P. Couratier

1.3k total citations
9 papers, 690 citations indexed

About

P. Couratier is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, P. Couratier has authored 9 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in P. Couratier's work include Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). P. Couratier is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). P. Couratier collaborates with scholars based in France, Switzerland and United States. P. Couratier's co-authors include Pierre‐Marie Preux, J.M. Vallat, Laurent Magy, Jean Claude Desport, B. Beaufrère, Yves Boirie‌, Pierre Clavelou, H. Derumeaux-Burel, Nathalie Guy and J.C. Desport and has published in prestigious journals such as American Journal of Clinical Nutrition, Environmental Research and Journal of the Neurological Sciences.

In The Last Decade

P. Couratier

8 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Couratier France 7 617 364 129 84 74 9 690
Vito Samarelli Italy 8 540 0.9× 289 0.8× 83 0.6× 108 1.3× 87 1.2× 8 603
Umberto Manera Italy 18 974 1.6× 568 1.6× 253 2.0× 183 2.2× 139 1.9× 83 1.1k
P. Corcia France 9 514 0.8× 300 0.8× 165 1.3× 91 1.1× 79 1.1× 12 606
Katy Mahoney United States 5 467 0.8× 371 1.0× 354 2.7× 68 0.8× 76 1.0× 6 745
Maurizio Grassano Italy 14 554 0.9× 338 0.9× 133 1.0× 89 1.1× 70 0.9× 40 598
Elisabetta Zucchi Italy 12 432 0.7× 205 0.6× 201 1.6× 102 1.2× 92 1.2× 33 634
Christina Fournier United States 14 398 0.6× 254 0.7× 195 1.5× 73 0.9× 66 0.9× 30 583
Karissa Arthur United States 5 319 0.5× 171 0.5× 129 1.0× 98 1.2× 108 1.5× 9 458
James T. Caroscio United States 11 433 0.7× 176 0.5× 144 1.1× 83 1.0× 62 0.8× 12 648
Sonja W. de Jong Netherlands 8 612 1.0× 331 0.9× 189 1.5× 71 0.8× 103 1.4× 9 704

Countries citing papers authored by P. Couratier

Since Specialization
Citations

This map shows the geographic impact of P. Couratier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Couratier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Couratier more than expected).

Fields of papers citing papers by P. Couratier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Couratier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Couratier. The network helps show where P. Couratier may publish in the future.

Co-authorship network of co-authors of P. Couratier

This figure shows the co-authorship network connecting the top 25 collaborators of P. Couratier. A scholar is included among the top collaborators of P. Couratier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Couratier. P. Couratier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Corcia, Philippe, Frank S. de Boer, Sophie Marguet, et al.. (2025). Epidemiology, disease evolution and economic burden of amyotrophic lateral sclerosis in France using the French national health data system. Brain Communications. 7(4). fcaf292–fcaf292.
2.
Corcia, Philippe, P. Couratier, & Patrick Vourc’h. (2021). The future of ALS might move towards Genetic Therapy. Revue Neurologique. 177(6). 613–614. 1 indexed citations
3.
4.
Corcia, Philippe, et al.. (2018). Staging amyotrophic lateral sclerosis: A new focus on progression. Revue Neurologique. 175(5). 277–282. 14 indexed citations
5.
Couratier, P., Philippe Corcia, Géraldine Lautrette, Marie Nicol, & Benôıt Marin. (2017). ALS and frontotemporal dementia belong to a common disease spectrum. Revue Neurologique. 173(5). 273–279. 51 indexed citations
6.
Bouteloup, Corinne, J.C. Desport, Pierre Clavelou, et al.. (2009). Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of Neurology. 256(8). 1236–1242. 257 indexed citations
7.
Desport, Jean Claude, Pierre‐Marie Preux, Laurent Magy, et al.. (2001). Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. American Journal of Clinical Nutrition. 74(3). 328–334. 267 indexed citations
8.
Preux, Pierre‐Marie, Michel Druet‐Cabanac, William Macharia, et al.. (2000). Parkinson’s Disease and Environmental Factors. Neuroepidemiology. 19(6). 333–337. 57 indexed citations
9.
Vallat, Jean‐Michel, et al.. (1996). Link between peripheral neuropathy and monoclonal dysglobulinemia: a study of 66 cases. Journal of the Neurological Sciences. 137(2). 124–130. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026